Cargando…
Taxanes in the elderly patient with metastatic breast cancer
More than 40% of all breast cancer cases are diagnosed in patients aged ≥65 years, accounting for an ever-increasing disease burden in the elderly. Historically, however, this growing population of breast cancer patients has been underrepresented in clinical trials, resulting in a paucity of data th...
Autor principal: | Yardley, Denise A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567240/ https://www.ncbi.nlm.nih.gov/pubmed/26379446 http://dx.doi.org/10.2147/BCTT.S87638 |
Ejemplares similares
-
Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Publicado: (2019) -
Taxanes for the Treatment of Metastatic Breast Cancer
por: Gradishar, W.J.
Publicado: (2012) -
Gemcitabine and taxanes in metastatic breast cancer: a systematic review
por: Gudena, Vinay, et al.
Publicado: (2008) -
Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009) -
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
por: Rivera, Edgardo, et al.
Publicado: (2015)